Fig. 7: Longitudinal evolution of different antibody parameters against MARV following infection in MVD survivors over years. | Nature Communications

Fig. 7: Longitudinal evolution of different antibody parameters against MARV following infection in MVD survivors over years.

From: Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design

Fig. 7

Schematic displaying the differential evolution of virion-binding IgG in ELISA and MARV neutralization titers, MARV specific IgM vs IgG vs IgA, antibody affinity maturation and Fc-receptor interaction across MARV proteome during convalescent phase over years in MVD survivors. The study data only portrays the antibody kinetics in the convalescent phase (post 12-months) in these MVD survivors.

Back to article page